GL1X · GenesisL1 explorer

Research workbench

PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3- phenylpropanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4- methylthiazol-5-YL)BENZYL)PYRROLIDINE-2-carboxamide (ligand 14)

Analyse PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4W9K
Type
protein
Length
1,331 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
UniProt
Q15370, Q15369, P40337
Ligands
3JO
Pockets
8 · best druggability 0.63

Structure

x-ray diffraction · 9 distinct chains · 28% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, G, JTranscription elongation factor B polypeptide 2protein10315% helix, 39% strandQ15370
BTranscription elongation factor B polypeptide 1protein8649% helix, 15% strandQ15369
CVon hippel-lindau disease tumor suppressorprotein14126% helix, 30% strandP40337
DTranscription elongation factor B polypeptide 2protein10215% helix, 37% strandQ15370
E, HTranscription elongation factor B polypeptide 1protein8844% helix, 15% strandQ15369
FVon hippel-lindau disease tumor suppressorprotein14427% helix, 29% strandP40337
IVon hippel-lindau disease tumor suppressorprotein14223% helix, 30% strandP40337
KTranscription elongation factor B polypeptide 1protein8848% helix, 15% strandQ15369
LVon hippel-lindau disease tumor suppressorprotein14321% helix, 29% strandP40337

Ligands and binding sites

  • 3JO · N-acetyl-L-phenylalanyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide · ligand · 4 copies · chains C, L, F, I

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12740.630.80433JO
22340.620.81363JO
31640.440.7528empty
41320.380.7324empty
51330.360.7323empty

Interfaces

18 interfaces between chains.

  • G–H · 1141 Ų buried · 12 hydrogen bonds · protein-protein
  • J–K · 1138 Ų buried · 13 hydrogen bonds · protein-protein
  • D–E · 1131 Ų buried · 15 hydrogen bonds · protein-protein
  • A–B · 1125 Ų buried · 14 hydrogen bonds · protein-protein
  • E–F · 1043 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (artifact).

Compared structures

  • 4W9K · pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.